{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "d50d7193-5564-4a4a-a2c9-8fbbc15b9510",
   "metadata": {},
   "outputs": [],
   "source": [
    "num_positives = 8\n",
    "num_negatives_per_positive = 4"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "fcaf1679-9d02-460a-b15a-79cfdcb8b883",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Load entire corpus\n",
    "import json\n",
    "def load_jsonl(path):\n",
    "    with open(path) as f:\n",
    "        return [json.loads(i) for i in f.readlines()]\n",
    "        \n",
    "corpus = load_jsonl(\"/gallery_louvre/dayoon.ko/research/sds/src/datasets/trec-covid/corpus.jsonl\")\n",
    "corpus_dict = {}\n",
    "for item in corpus:\n",
    "    corpus_dict[item[\"_id\"]] = item[\"text\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "6ed7390a-c249-4131-827a-32c174217c92",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>n-query</th>\n",
       "      <th>recall</th>\n",
       "      <th>precision</th>\n",
       "      <th>f1</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>corpus-id</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>n15i01tn</th>\n",
       "      <td>2</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>k9lcpjyo</th>\n",
       "      <td>2</td>\n",
       "      <td>0.500000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.666667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jbtrdvhe</th>\n",
       "      <td>6</td>\n",
       "      <td>0.166667</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.285714</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>juz9jnfk</th>\n",
       "      <td>5</td>\n",
       "      <td>0.400000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.571429</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4dtk1kyh</th>\n",
       "      <td>3</td>\n",
       "      <td>0.333333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.500000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>yb5kf0u2</th>\n",
       "      <td>3</td>\n",
       "      <td>0.333333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.500000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48ay8yl3</th>\n",
       "      <td>4</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wzv8n34v</th>\n",
       "      <td>3</td>\n",
       "      <td>0.333333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.500000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>qq22z25y</th>\n",
       "      <td>2</td>\n",
       "      <td>0.500000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.666667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5czqzmvj</th>\n",
       "      <td>2</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1177 rows × 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           n-query    recall  precision        f1\n",
       "corpus-id                                        \n",
       "n15i01tn         2  0.000000        0.0  0.000000\n",
       "k9lcpjyo         2  0.500000        1.0  0.666667\n",
       "jbtrdvhe         6  0.166667        1.0  0.285714\n",
       "juz9jnfk         5  0.400000        1.0  0.571429\n",
       "4dtk1kyh         3  0.333333        1.0  0.500000\n",
       "...            ...       ...        ...       ...\n",
       "yb5kf0u2         3  0.333333        1.0  0.500000\n",
       "48ay8yl3         4  0.000000        0.0  0.000000\n",
       "wzv8n34v         3  0.333333        1.0  0.500000\n",
       "qq22z25y         2  0.500000        1.0  0.666667\n",
       "5czqzmvj         2  0.000000        0.0  0.000000\n",
       "\n",
       "[1177 rows x 4 columns]"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Load succ and fail csv files\n",
    "import pandas as pd\n",
    "path = \"/gallery_louvre/dayoon.ko/research/sds/retrieval/results/multilingual-e5-large/trec-covid-n-query-mt-2.csv\"\n",
    "df = pd.read_csv(path)\n",
    "df = df.drop('Unnamed: 0', axis=1)\n",
    "df = df.set_index(\"corpus-id\")\n",
    "df\n",
    "# Get succ and fail corpus-id\n",
    "#meta = df.to_dict()\n",
    "#print(meta)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "dd3ccb42-9719-4709-95f2-9e09c2da20f6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2.0"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.loc[\"n15i01tn\"][\"n-query\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "id": "7bfe350f-13e5-43f5-b507-49d1b421036d",
   "metadata": {},
   "outputs": [],
   "source": [
    "def filter_data(res):\n",
    "    for i in res:\n",
    "        i[\"retrieval\"] = [j for j in i[\"retrieval\"] if i[\"_id\"] != j]\n",
    "    return res"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "id": "617da01d-0e95-4265-a9c6-535724da2808",
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_ret_map(pth):\n",
    "    pth1 = path.replace(\".csv\", \"-d2d-retrieval.jsonl\")\n",
    "    res1 = load_jsonl(pth1)\n",
    "    res1 = filter_data(res1)\n",
    "    res1 = {i[\"_id\"]: i[\"retrieval\"] for i in res1}\n",
    "    pth2 = path.replace(\".csv\", \"-d2d2d-retrieval.jsonl\")\n",
    "    res2 = load_jsonl(pth2)\n",
    "    res2 = filter_data(res2)\n",
    "    res2 = {i[\"_id\"]: i[\"retrieval\"][1:] for i in res2}\n",
    "    results = {}\n",
    "    for qid, ret_ids in res1.items():\n",
    "        selected_rets = {}\n",
    "        for ret_id in ret_ids[:num_positives * 2]:\n",
    "            ret2_ids = res2[ret_id]\n",
    "            ret2_ids_selected = [i for i in ret2_ids if i not in ret_ids and i != qid]\n",
    "            ret2_ids_selected = ret2_ids_selected[:num_negatives_per_positive]\n",
    "            if len(ret2_ids_selected) < num_negatives_per_positive:\n",
    "                continue\n",
    "            selected_rets[ret_id] = ret2_ids_selected\n",
    "            if len(selected_rets) == num_positives:\n",
    "                break\n",
    "        results[qid] = selected_rets\n",
    "    return results\n",
    "        \n",
    "ret_map = get_ret_map(path)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "da59570f-c46d-48ac-8f91-0967485ad9bc",
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_dataset(ret_map):\n",
    "    dataset = []\n",
    "    for query_id, rets1 in ret_map.items():\n",
    "        for pos_id, neg_ids in rets1.items():\n",
    "            query_meta = df.loc[query_id]\n",
    "            query = corpus_dict[query_id]\n",
    "            positive = [corpus_dict[pos_id]]\n",
    "            negatives = [corpus_dict[idx] for idx in neg_ids]\n",
    "            dataset.append({\n",
    "                \"_id\": query_id,\n",
    "                \"recall\": query_meta[\"recall\"],\n",
    "                \"precision\": query_meta[\"precision\"],\n",
    "                \"f1\": query_meta[\"f1\"],\n",
    "                \"query\": query,\n",
    "                \"pos\": positive,\n",
    "                \"neg\": negatives,\n",
    "            })\n",
    "    return dataset \n",
    "\n",
    "dataset = get_dataset(ret_map)\n",
    "            "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "id": "a92d244c-40af-478a-afaa-dd6fedd8293a",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "with open(\"trec-covid/ood_all.json\", \"w\") as f:\n",
    "    json.dump(dataset, f, indent=2)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cc7c0473-1ee3-4383-a065-840b35444e9d",
   "metadata": {
    "jp-MarkdownHeadingCollapsed": true
   },
   "source": [
    "#### Deprecated"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "e7f160e6-28da-4a8e-a6da-d8cb6d0b69ef",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "ename": "FileNotFoundError",
     "evalue": "[Errno 2] No such file or directory: '/gallery_louvre/dayoon.ko/research/sds/retrieval/results/multilingual-e5-large/trec-covid-n-query-mt-2-d2-retrieval.jsonl'",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mFileNotFoundError\u001b[0m                         Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[49], line 27\u001b[0m\n\u001b[1;32m     16\u001b[0m         dataset\u001b[38;5;241m.\u001b[39mappend({\n\u001b[1;32m     17\u001b[0m             \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m_id\u001b[39m\u001b[38;5;124m\"\u001b[39m: query_id,\n\u001b[1;32m     18\u001b[0m             \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mrecall\u001b[39m\u001b[38;5;124m\"\u001b[39m: query_meta[\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mrecall\u001b[39m\u001b[38;5;124m\"\u001b[39m],\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m     23\u001b[0m             \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mneg\u001b[39m\u001b[38;5;124m\"\u001b[39m: negatives,\n\u001b[1;32m     24\u001b[0m         })\n\u001b[1;32m     25\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m dataset\n\u001b[0;32m---> 27\u001b[0m dataset \u001b[38;5;241m=\u001b[39m \u001b[43mget_dataset\u001b[49m\u001b[43m(\u001b[49m\u001b[43mpath\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mmeta\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m     28\u001b[0m \u001b[38;5;28mprint\u001b[39m(dataset[\u001b[38;5;241m0\u001b[39m])\n",
      "Cell \u001b[0;32mIn[49], line 3\u001b[0m, in \u001b[0;36mget_dataset\u001b[0;34m(path, meta)\u001b[0m\n\u001b[1;32m      1\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21mget_dataset\u001b[39m(path, meta):\n\u001b[1;32m      2\u001b[0m     path \u001b[38;5;241m=\u001b[39m path\u001b[38;5;241m.\u001b[39mreplace(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m.csv\u001b[39m\u001b[38;5;124m\"\u001b[39m, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m-d2-retrieval.jsonl\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[0;32m----> 3\u001b[0m     result \u001b[38;5;241m=\u001b[39m \u001b[43mload_jsonl\u001b[49m\u001b[43m(\u001b[49m\u001b[43mpath\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m      5\u001b[0m     dataset \u001b[38;5;241m=\u001b[39m []\n\u001b[1;32m      6\u001b[0m     \u001b[38;5;28;01mfor\u001b[39;00m i \u001b[38;5;129;01min\u001b[39;00m result:\n\u001b[1;32m      7\u001b[0m         \u001b[38;5;66;03m# Filter top-1 \u001b[39;00m\n",
      "Cell \u001b[0;32mIn[5], line 4\u001b[0m, in \u001b[0;36mload_jsonl\u001b[0;34m(path)\u001b[0m\n\u001b[1;32m      3\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21mload_jsonl\u001b[39m(path):\n\u001b[0;32m----> 4\u001b[0m     \u001b[38;5;28;01mwith\u001b[39;00m \u001b[38;5;28;43mopen\u001b[39;49m\u001b[43m(\u001b[49m\u001b[43mpath\u001b[49m\u001b[43m)\u001b[49m \u001b[38;5;28;01mas\u001b[39;00m f:\n\u001b[1;32m      5\u001b[0m         \u001b[38;5;28;01mreturn\u001b[39;00m [json\u001b[38;5;241m.\u001b[39mloads(i) \u001b[38;5;28;01mfor\u001b[39;00m i \u001b[38;5;129;01min\u001b[39;00m f\u001b[38;5;241m.\u001b[39mreadlines()]\n",
      "File \u001b[0;32m~/anaconda3/envs/sds/lib/python3.9/site-packages/IPython/core/interactiveshell.py:310\u001b[0m, in \u001b[0;36m_modified_open\u001b[0;34m(file, *args, **kwargs)\u001b[0m\n\u001b[1;32m    303\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m file \u001b[38;5;129;01min\u001b[39;00m {\u001b[38;5;241m0\u001b[39m, \u001b[38;5;241m1\u001b[39m, \u001b[38;5;241m2\u001b[39m}:\n\u001b[1;32m    304\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mValueError\u001b[39;00m(\n\u001b[1;32m    305\u001b[0m         \u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mIPython won\u001b[39m\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mt let you open fd=\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mfile\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m by default \u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    306\u001b[0m         \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mas it is likely to crash IPython. If you know what you are doing, \u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    307\u001b[0m         \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124myou can use builtins\u001b[39m\u001b[38;5;124m'\u001b[39m\u001b[38;5;124m open.\u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    308\u001b[0m     )\n\u001b[0;32m--> 310\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mio_open\u001b[49m\u001b[43m(\u001b[49m\u001b[43mfile\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[0;31mFileNotFoundError\u001b[0m: [Errno 2] No such file or directory: '/gallery_louvre/dayoon.ko/research/sds/retrieval/results/multilingual-e5-large/trec-covid-n-query-mt-2-d2-retrieval.jsonl'"
     ]
    }
   ],
   "source": [
    "def get_dataset(path, ret_map):\n",
    "    path = path.replace(\".csv\", \"-d2-retrieval.jsonl\")\n",
    "    result = load_jsonl(path)\n",
    "\n",
    "    dataset = []\n",
    "    for i in result:\n",
    "        # Filter top-1 \n",
    "        if i[\"_id\"] == i[\"retrieval\"]:\n",
    "            continue\n",
    "        query_id = i[\"_id\"]\n",
    "        query_meta = df.loc[query_id]\n",
    "        query = corpus_dict[i[\"_id\"]]\n",
    "        positive = [corpus_dict[i[\"retrieval\"]]]\n",
    "        negatives = [corpus_dict[idx] for idx in i[\"retrieval2\"]\n",
    "                    if idx][1:num_negatives_per_positive+1]\n",
    "        dataset.append({\n",
    "            \"_id\": query_id,\n",
    "            \"recall\": query_meta[\"recall\"],\n",
    "            \"precision\": query_meta[\"precision\"],\n",
    "            \"f1\": query_meta[\"f1\"],\n",
    "            \"query\": query,\n",
    "            \"pos\": positive,\n",
    "            \"neg\": negatives,\n",
    "        })\n",
    "    return dataset\n",
    "        \n",
    "dataset = get_dataset(path, ret_map)\n",
    "print(dataset[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "0a8fdd0b-0421-422e-b9b5-8dfb1dfdfbb1",
   "metadata": {},
   "outputs": [],
   "source": [
    "import random\n",
    "\n",
    "negs = [i[\"text\"] for i in random.sample(corpus, 20) if len(i[\"text\"]) > 0][:5]\n",
    "\n",
    "def generate_rand_neg_dataset(docs, positives, negatives):\n",
    "    dataset = []\n",
    "    for i in range(len(docs)):\n",
    "        query = docs[i]\n",
    "        positives_selected = []\n",
    "        negatives_selected = []\n",
    "        for j, doc in enumerate(positives[i]):\n",
    "            if len(negatives[i][j]) == num_negatives_per_positive:\n",
    "                positives_selected.append(doc)\n",
    "                negatives_selected.append(negs)\n",
    "            if len(positives_selected) == 4:\n",
    "                break\n",
    "        for p, ns in zip(positives_selected, negatives_selected):\n",
    "            dataset.append({\n",
    "                \"query\": query,\n",
    "                \"pos\": [p],\n",
    "                \"neg\": ns\n",
    "            })\n",
    "    return dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "23850017-511e-4bb3-9ea6-ded6c2a29a26",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'query': 'SARS-CoV-2 has caused tens of thousands of infections and more than one thousand deaths. There are currently no registered therapies for treating coronavirus infections. Because of time consuming process of new drug development, drug repositioning may be the only solution to the epidemic of sudden infectious diseases. We systematically analyzed all the proteins encoded by SARS-CoV-2 genes, compared them with proteins from other coronaviruses, predicted their structures, and built 19 structures that could be done by homology modeling. By performing target-based virtual ligand screening, a total of 21 targets (including two human targets) were screened against compound libraries including ZINC drug database and our own database of natural products. Structure and screening results of important targets such as 3-chymotrypsin-like protease (3CLpro), Spike, RNA-dependent RNA polymerase (RdRp), and papain like protease (PLpro) were discussed in detail. In addition, a database of 78 commonly used anti-viral drugs including those currently on the market and undergoing clinical trials for SARS-CoV-2 was constructed. Possible targets of these compounds and potential drugs acting on a certain target were predicted. This study will provide new lead compounds and targets for further in vitro and in vivo studies of SARS-CoV-2, new insights for those drugs currently ongoing clinical studies, and also possible new strategies for drug repositioning to treat SARS-CoV-2 infections.', 'pos': ['The outbreak of a novel human coronavirus (SARS-CoV-2) has evolved into global health emergency, infecting hundreds of thousands of people worldwide. We have identified experimental data on the inhibitory activity of compounds tested against closely related (96% sequence identity, 100% active site conservation) protease of SARS-CoV and employed this data to build QSAR models for this dataset. We employed these models for virtual screening of all drugs from DrugBank, including compounds in clinical trials. Molecular docking and similarity search approaches were explored in parallel with QSAR modeling, but molecular docking failed to correctly discriminate between experimentally active and inactive compounds. As a result of our studies, we recommended 41 approved, experimental, or investigational drugs as potential agents against SARS-CoV-2 acting as putative inhibitors of Mpro. Ten compounds with feasible prices were purchased and are awaiting the experimental validation..'], 'neg': ['To investigate the influence of different menstrual phases on the Bispectral Index (BIS) during dexmedetomidine (Dex) sedation, 40 patients with regular menstrual cycle, American Society of Anesthesiologists I-II, aged 18-40 years, undergoing selective gynecologic laparoscopic surgery, were enrolled. According to different menstrual phases and the serum progesterone concentration, they were divided into two groups: the follicular phase group (Group F) and the luteal phase group (Group L), and each group had 20 patients. Before anesthesia induction, patients were infused with an initial loading dose of Dex (1 μg/kg) for 10 minutes and then 0.5 μg/kg/h for 20 minutes. BIS and the changes in hemodynamic and respiratory parameters were recorded within those 30 minutes. Time to lower BIS to 70 and 60 in Group L was shorter than that in Group F (9.4 ± 1.3 minutes vs. 11.3 ± 2.1 minutes, p = 0.005; 11.3 ± 2.4 minutes vs. 14.0 ± 3.6 minutes, p = 0.021). The number of patients whose BIS reached 50 in Group L was greater than that in Group F (15 vs. 8, p < 0.05). The lowest BIS value in the Group L was lower than that in Group F (46.8 ± 6.3 vs. 55.3 ± 5.5, p = 0.006), and the heart rate of patients in both groups showed a decrease (p < 0.05). The sedative effect of Dex was more significant in patients during the luteal phase than during the follicular phase.', 'Two decades of growing resource availability from agencies and foundations in wealthy countries has transformed approaches to health in poorly resourced nations. This progress looks increasingly unstable as climate change, social unrest, and, now, disruptive pandemics present threats not only to health but also to the mechanisms that manage it, and to funding itself. The growth in “global health” schools, technology development laboratories, nongovernmental organizations and multilateral institutions in donor countries has delivered not only successes but also disappointment, and reflect a paradigm that is in many ways contrary to the principles of population-based ownership that they espouse. Although the COVID-19 crisis has underlined the importance of health access and health service capacity, we may have a limited window of opportunity in which to rethink the current model and improve both efficiency and effectiveness. With a dose of humility, we may all benefit from studying our own rhetoric on human-centered design and applying these principles across global health to ensure that our approach is effective, efficient, and defensible.', 'The Open Research Knowledge Graph (ORKG) provides machine-actionable access to scholarly literature that habitually is written in prose. Following the FAIR principles, the ORKG makes traditional, human-coded knowledge findable, accessible, interoperable, and reusable in a structured manner in accordance with the Linked Open Data paradigm. At the moment, in ORKG papers are described manually, but in the long run the semantic depth of the literature at scale needs automation. Operational Research is a suitable test case for this vision because the mathematical field and, hence, its publication habits are highly structured: A mundane problem is formulated as a mathematical model, solved or approximated numerically, and evaluated systematically. We study the existing literature with respect to the Assembly Line Balancing Problem and derive a semantic description in accordance with the ORKG. Eventually, selected papers are ingested to test the semantic description and refine it further.', 'Viruses depend on their hosts to complete their replication cycles; they exploit cellular receptors for entry and hijack cellular functions to replicate their genome, assemble progeny virions and spread. Recently, genome-scale CRISPR–Cas screens have been used to identify host factors that are required for virus replication, including the replication of clinically relevant viruses such as Zika virus, West Nile virus, dengue virus and hepatitis C virus. In this Review, we discuss the technical aspects of genome-scale knockout screens using CRISPR–Cas technology, and we compare these screens with alternative genetic screening technologies. The relative ease of use and reproducibility of CRISPR–Cas make it a powerful tool for probing virus–host interactions and for identifying new antiviral targets.', 'The first person-to-person transmission of the 2019-novel coronavirus in Italy on 21 February 2020 led to an infection chain that represents one of the largest known COVID-19 outbreaks outside Asia. Hospitals have been forced to reorganized their units in response to prepare for an unforeseen healthcare emergency. In this context, our laboratory (Molecular and Genomic Diagnostics Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS) re-modulated its priorities by temporarily interrupting most of the molecular tests guaranteeing only those considered \"urgent\" and not postponable. In particular, this paper details changes regarding the execution of germline BRCA (gBRCA) testing in our laboratory. A substantial reduction in gBRCA testing (about 60%) compared to the first 2 months of the current year was registered, but the requests have not been reset. The requesting physicians were mainly gynaecologists and oncologists. These evidences further emphasize the new era of gBRCA testing in the management of cancer patients and confirms definitively the integration of gBRCA testing/Next Generation Sequencing (NGS) into clinical oncology. Finally, a re-organization of gBRCA testing in our Unit, mainly related to delayed and reduced arrival of tests was necessary, ensuring, however, a high-quality standard and reliability, mandatory for gBRCA testing in a clinical setting.']}\n",
      "{'query': \"Abstract COVID-19 was originated from Wuhan city of Hubei Province in China in December 2019. Since then it has spread in more than 210 countries and territories. It is a viral disease due to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. The patients show flu-like symptoms with a dry cough, sore throat, high fever, and breathing problems. The disease due to SARS-CoV-2 was named as COVID-19. About 2.2 million people have been infected with more than 0.15 million deaths globally. The United States of America is the most affected country with the highest patients of about 0.7 million. Despite great efforts, there is no treatment of this disease. However, prevention and management are the best options. This article describes SARS-CoV-2, disease, prevention and management, treatment and social impact on society. It was analyzed that a combination of antiviral drugs with hydroxyl-chloroquine and azithromycin (with the consultation of a medical practitioner) may be the best option to treat the patients, depending on the patient's conditions and symptoms. However, Unani therapy may be useful along with allopathic treatment. It is urgently advised and requested that all the persons should follow the preventive measures, managements and quarantine strictly without any religious discrepancy otherwise the situation may be the worst. Also, there is an urgent requirement to educate our new generation for science and technology to fight against any such disaster in future; if any. There is no need to be panic and proper prevention and management are essential to combat this disease. This article may be useful to create awareness among the public, to prevent, manage and treat COVID-19.\", 'pos': [\"INTRODUCTION: The Coronavirus disease-19 (COVID-19) caused by the novel beta coronavirus named Severe Acute Respiratory Syndromecoronavirus-2 (SARS-CoV-2) started in late December 2019 in Wuhan, China. Within a short span, COVID-19 was declared a global public health emergency affecting 214 countries with 5,939,234 confirmed cases and 3,67,255 deaths as of 30 May, 2020. With limited knowledge about SARS-CoV-2, no approved treatment or vaccine is available till date. AREAS COVERED: We performed a review of literature on PubMed on the SARS-CoV-2 virus and COVID-19 illness including trials of preventive and therapeutic measures. This review presents the basic biology of coronaviruses, epidemiology of COVID-19, clinical presentations, investigational therapies and vaccines, infection prevention and control measures and the lessons from the present pandemic. EXPERT OPINION: The scale of the outbreak has brought the governments, healthcare professionals and scientists around the world under tremendous pressure to devise control strategies and develop novel prevention measures. While availability of vaccine for COVID-19 may take time, the disease may be contained through hand hygiene, physical distancing, travel restriction and aggressive steps such as 'lockdown'. Clinical trials at different phases are ongoing across different countries to expedite development of effective drugs and vaccine to overcome the pandemic.\"], 'neg': ['To investigate the influence of different menstrual phases on the Bispectral Index (BIS) during dexmedetomidine (Dex) sedation, 40 patients with regular menstrual cycle, American Society of Anesthesiologists I-II, aged 18-40 years, undergoing selective gynecologic laparoscopic surgery, were enrolled. According to different menstrual phases and the serum progesterone concentration, they were divided into two groups: the follicular phase group (Group F) and the luteal phase group (Group L), and each group had 20 patients. Before anesthesia induction, patients were infused with an initial loading dose of Dex (1 μg/kg) for 10 minutes and then 0.5 μg/kg/h for 20 minutes. BIS and the changes in hemodynamic and respiratory parameters were recorded within those 30 minutes. Time to lower BIS to 70 and 60 in Group L was shorter than that in Group F (9.4 ± 1.3 minutes vs. 11.3 ± 2.1 minutes, p = 0.005; 11.3 ± 2.4 minutes vs. 14.0 ± 3.6 minutes, p = 0.021). The number of patients whose BIS reached 50 in Group L was greater than that in Group F (15 vs. 8, p < 0.05). The lowest BIS value in the Group L was lower than that in Group F (46.8 ± 6.3 vs. 55.3 ± 5.5, p = 0.006), and the heart rate of patients in both groups showed a decrease (p < 0.05). The sedative effect of Dex was more significant in patients during the luteal phase than during the follicular phase.', 'Two decades of growing resource availability from agencies and foundations in wealthy countries has transformed approaches to health in poorly resourced nations. This progress looks increasingly unstable as climate change, social unrest, and, now, disruptive pandemics present threats not only to health but also to the mechanisms that manage it, and to funding itself. The growth in “global health” schools, technology development laboratories, nongovernmental organizations and multilateral institutions in donor countries has delivered not only successes but also disappointment, and reflect a paradigm that is in many ways contrary to the principles of population-based ownership that they espouse. Although the COVID-19 crisis has underlined the importance of health access and health service capacity, we may have a limited window of opportunity in which to rethink the current model and improve both efficiency and effectiveness. With a dose of humility, we may all benefit from studying our own rhetoric on human-centered design and applying these principles across global health to ensure that our approach is effective, efficient, and defensible.', 'The Open Research Knowledge Graph (ORKG) provides machine-actionable access to scholarly literature that habitually is written in prose. Following the FAIR principles, the ORKG makes traditional, human-coded knowledge findable, accessible, interoperable, and reusable in a structured manner in accordance with the Linked Open Data paradigm. At the moment, in ORKG papers are described manually, but in the long run the semantic depth of the literature at scale needs automation. Operational Research is a suitable test case for this vision because the mathematical field and, hence, its publication habits are highly structured: A mundane problem is formulated as a mathematical model, solved or approximated numerically, and evaluated systematically. We study the existing literature with respect to the Assembly Line Balancing Problem and derive a semantic description in accordance with the ORKG. Eventually, selected papers are ingested to test the semantic description and refine it further.', 'Viruses depend on their hosts to complete their replication cycles; they exploit cellular receptors for entry and hijack cellular functions to replicate their genome, assemble progeny virions and spread. Recently, genome-scale CRISPR–Cas screens have been used to identify host factors that are required for virus replication, including the replication of clinically relevant viruses such as Zika virus, West Nile virus, dengue virus and hepatitis C virus. In this Review, we discuss the technical aspects of genome-scale knockout screens using CRISPR–Cas technology, and we compare these screens with alternative genetic screening technologies. The relative ease of use and reproducibility of CRISPR–Cas make it a powerful tool for probing virus–host interactions and for identifying new antiviral targets.', 'The first person-to-person transmission of the 2019-novel coronavirus in Italy on 21 February 2020 led to an infection chain that represents one of the largest known COVID-19 outbreaks outside Asia. Hospitals have been forced to reorganized their units in response to prepare for an unforeseen healthcare emergency. In this context, our laboratory (Molecular and Genomic Diagnostics Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS) re-modulated its priorities by temporarily interrupting most of the molecular tests guaranteeing only those considered \"urgent\" and not postponable. In particular, this paper details changes regarding the execution of germline BRCA (gBRCA) testing in our laboratory. A substantial reduction in gBRCA testing (about 60%) compared to the first 2 months of the current year was registered, but the requests have not been reset. The requesting physicians were mainly gynaecologists and oncologists. These evidences further emphasize the new era of gBRCA testing in the management of cancer patients and confirms definitively the integration of gBRCA testing/Next Generation Sequencing (NGS) into clinical oncology. Finally, a re-organization of gBRCA testing in our Unit, mainly related to delayed and reduced arrival of tests was necessary, ensuring, however, a high-quality standard and reliability, mandatory for gBRCA testing in a clinical setting.']}\n"
     ]
    }
   ],
   "source": [
    "succ_dataset = generate_rand_neg_dataset(succ_docs, succ_positives, succ_negatives)\n",
    "print(succ_dataset[0])\n",
    "with open(\"id_randneg_dataset/trec-covid-succ.json\", \"w\") as f:\n",
    "    json.dump(succ_dataset, f, indent=2)\n",
    "\n",
    "\n",
    "fail_dataset = generate_rand_neg_dataset(fail_docs, fail_positives, fail_negatives)\n",
    "print(fail_dataset[0])\n",
    "with open(\"ood_randneg_dataset/trec-covid-fail.json\", \"w\") as f:\n",
    "    json.dump(fail_dataset, f, indent=2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "id": "119b40bc-a13c-4d8d-a815-c6c0ffd84f46",
   "metadata": {},
   "outputs": [],
   "source": [
    "succ_negatives = get_negatives(succ_path)\n",
    "succ_negatives_selected = [succ_negatives[i] for i in succ_ids_selected]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "id": "e4199464-75a2-4ac4-8a47-077ed3b266ce",
   "metadata": {},
   "outputs": [],
   "source": [
    "def generate_dataset(docs, positives, negatives):\n",
    "    dataset = []\n",
    "    for i in range(len(docs)):\n",
    "        query = docs[i]\n",
    "        positives_selected = []\n",
    "        negatives_selected = []\n",
    "        for j, doc in enumerate(positives[i]):\n",
    "            if len(negatives[i][j]) == num_negatives_per_positive:\n",
    "                positives_selected.append(doc)\n",
    "                negatives_selected.append(negatives[i][j])\n",
    "            if len(positives_selected) == 4:\n",
    "                break\n",
    "        for p, ns in zip(positives_selected, negatives_selected):\n",
    "            dataset.append({\n",
    "                \"query\": query,\n",
    "                \"pos\": [p],\n",
    "                \"neg\": ns\n",
    "            })\n",
    "    return dataset\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "id": "18c2100d-ba75-40e9-8ceb-46194d5a264d",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'query': 'Importance: The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented challenge to identify effective drugs for prevention and treatment. Given the rapid pace of scientific discovery and clinical data generated by the large number of people rapidly infected by SARS-CoV-2, clinicians need accurate evidence regarding effective medical treatments for this infection. Observations: No proven effective therapies for this virus currently exist. The rapidly expanding knowledge regarding SARS-CoV-2 virology provides a significant number of potential drug targets. The most promising therapy is remdesivir. Remdesivir has potent in vitro activity against SARS-CoV-2, but it is not US Food and Drug Administration approved and currently is being tested in ongoing randomized trials. Oseltamivir has not been shown to have efficacy, and corticosteroids are currently not recommended. Current clinical evidence does not support stopping angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients with COVID-19. Conclusions and Relevance: The COVID-19 pandemic represents the greatest global public health crisis of this generation and, potentially, since the pandemic influenza outbreak of 1918. The speed and volume of clinical trials launched to investigate potential therapies for COVID-19 highlight both the need and capability to produce high-quality evidence even in the middle of a pandemic. No therapies have been shown effective to date.', 'pos': [\"BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), termed coronavirus disease 2019 (COVID-19) by the World Health Organization, is a newly emerging zoonotic agent that emerged in China in December 2019. No specific treatment for COVID-19 is currently available. Usual palliative treatment includes maintaining hydration and nutrition and controlling fever and cough. The clinical severity and extent of transmission need to be determined, and therapeutic options need to be developed and optimized. METHODS: The present review discusses the recent repurposing of drugs for COVID-19 treatment. RESULTS: Several compounds, including remdesivir, lopinavir, ritonavir, interferon-ß, ribavirin, chloroquine/hydroxychloroquine, azithromycin, tocilizumab, and ivermectin, have emerged as promising alternatives. They block the virus from entering host cells, prevent viral replication, and attenuate exacerbation of the host's immune response. CONCLUSION: Although some evidence indicates the positive actions of different classes of compounds for the treatment of COVID-19, few clinical assays have been established to definitively demonstrate their therapeutic value in humans. Multicenter clinical studies are urgently needed to validate and standardize therapeutic regimens that involve these agents. Although science has not yet presented us with a specific drug against COVID-19, the repurposing of drugs appears to be promising in our fight against this devastating disease.\"], 'neg': ['The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has resulted in > 500,000 deaths worldwide, including > 125,000 deaths in the U.S. since its emergence in late December 2019 and June 2020. Neither curative anti-viral drugs nor a protective vaccine is currently available for the treatment and prevention of COVID-19. Recently, new clinical syndromes associated with coagulopathy and vasculopathy have emerged as a cause of sudden death and other serious clinical manifestations in younger patients infected with SARS-CoV-2 infection. Angiotensin converting enzyme 2 (ACE2), the receptor for SARS-CoV-2 and other coronaviruses, is a transmembrane protein expressed by lung alveolar epithelial cells, enterocytes, and vascular endothelial cells, whose physiologic role is to induce the maturation of angiotensin I to generate angiotensin 1-7, a peptide hormone that controls vasoconstriction and blood pressure. In this review, we provide the general context of the molecular and cellular mechanisms of SARS-CoV-2 infection with a focus on endothelial cells, describe the vasculopathy and coagulopathy syndromes in patients with SARS-CoV-2, and outline current understanding of the underlying mechanistic aspects.', 'The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has resulted in > 500,000 deaths worldwide, including > 125,000 deaths in the U.S. since its emergence in late December 2019 and June 2020. Neither curative anti-viral drugs nor a protective vaccine is currently available for the treatment and prevention of COVID-19. Recently, new clinical syndromes associated with coagulopathy and vasculopathy have emerged as a cause of sudden death and other serious clinical manifestations in younger patients infected with SARS-CoV-2 infection. Angiotensin converting enzyme 2 (ACE2), the receptor for SARS-CoV-2 and other coronaviruses, is a transmembrane protein expressed by lung alveolar epithelial cells, enterocytes, and vascular endothelial cells, whose physiologic role is to induce the maturation of angiotensin I to generate angiotensin 1-7, a peptide hormone that controls vasoconstriction and blood pressure. In this review, we provide the general context of the molecular and cellular mechanisms of SARS-CoV-2 infection with a focus on endothelial cells, describe the vasculopathy and coagulopathy syndromes in patients with SARS-CoV-2, and outline current understanding of the underlying mechanistic aspects.', 'Coronavirus disease 2019 (COVID-19) is a global pandemic caused by a novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 infection of host cells occurs predominantly via binding of the viral surface spike protein to the human angiotensin-converting enzyme 2 (ACE2) receptor. Hypertension and pre-existing cardiovascular disease are risk factors for morbidity from COVID-19, and it remains uncertain whether the use of angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB) impacts infection and disease. Here, we aim to shed light on this question by assessing ACE2 expression in normal and diseased human myocardial samples profiled by bulk and single nucleus RNA-seq.', 'Abstract The pandemic of coronavirus disease 2019 (COVID-19) has emerged as a major health crisis, with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) having infected over a million people around the world within a few months of its identification as a human pathogen. Initially, SARS-CoV-2 infects cells in the respiratory system and causes inflammation and cell death. Subsequently, the virus spreads out and damages other vital organs and tissues, triggering a complicated spectrum of pathophysiological changes and symptoms, including cardiovascular complications. Acting as the receptor for SARS-CoV entering mammalian cells, angiotensin converting enzyme-2 (ACE2) plays a pivotal role in the regulation of cardiovascular cell function. Diverse clinical manifestations and laboratory abnormalities occur in patients with cardiovascular injury in COVID-19, characterizing the development of this complication, as well as providing clues to diagnosis and treatment. This review provides a summary of the rapidly appearing laboratory and clinical evidence for the pathophysiology and therapeutic approaches to COVID-19 pulmonary and cardiovascular complications.', 'Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents the most significant global public health crisis of this generation. From the beginning of the pandemic, several publications and on-line resources about different treatment lines have been done, and development effort in response to the COVID-19 pandemic to investigate potential therapies is unprecedented. Unfortunately, until now, there is not enough evidence to recommend any specific anti-COVID19 treatment. Randomized clinical trials and high-quality evidence, even in the middle of a pandemic, are needed. We provide a review of the latest published literature on the therapeutic strategies and current investigational lines for SARS-CoV-2.']}\n"
     ]
    }
   ],
   "source": [
    "succ_dataset_selected = generate_dataset(succ_docs_selected, succ_positives_selected, succ_negatives_selected)\n",
    "print(succ_dataset_selected[0])\n",
    "with open(\"trec-covid/ood_well_over_0.4.json\", \"w\") as f:\n",
    "    json.dump(succ_dataset_selected, f, indent=2)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b7b592b2-3d52-4e0c-b6c5-10d35d04e0ad",
   "metadata": {
    "jp-MarkdownHeadingCollapsed": true
   },
   "source": [
    "## OOD all consecutive"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "8eb9c65d-1f60-4e40-85a2-cc573df7ef32",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "No artists with labels found to put in legend.  Note that artists whose label start with an underscore are ignored when legend() is called with no argument.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "250 250 250\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<matplotlib.legend.Legend at 0x7fbdb8bbeb80>"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "pth = \"/gallery_louvre/dayoon.ko/research/sds/FlagEmbedding/FlagEmbedding/BGE_M3/\"\n",
    "\n",
    "def load_file(pth):\n",
    "    with open(pth) as f:\n",
    "        lines = f.readlines() \n",
    "    return lines \n",
    "    \n",
    "def get_recall_and_score_list(pth):\n",
    "    lines = load_file(pth)\n",
    "    gradnorms = []\n",
    "    for l in lines:\n",
    "        try: \n",
    "            sid = l.index(\"tensor(\") + len(\"tensor(\") \n",
    "            eid = sid + 5\n",
    "            gradnorms.append(float(l[sid:eid]))\n",
    "        except:\n",
    "            continue\n",
    "    recalls = []\n",
    "    for l in lines:\n",
    "        try: \n",
    "            sid = l.index(\"recall: \") + len(\"recall: \") \n",
    "            eid = sid + 5\n",
    "            recalls.append(int(float(l[sid:eid].strip()) * 100))\n",
    "        except:\n",
    "            continue\n",
    "    ids = []\n",
    "    for l in lines:\n",
    "        try:\n",
    "            sid = l.index(\"doc_id: \") + len(\"doc_id: \") \n",
    "            eid = sid\n",
    "            ids.append(l[sid:].strip())\n",
    "        except:\n",
    "            continue\n",
    "\n",
    "    gradnorms_selected = []\n",
    "    recalls_selected = []\n",
    "    ids_selected = []\n",
    "    func = min #lambda x: sum(x) / len(x)\n",
    "    for i in range(0, len(ids), 4):\n",
    "        gradnorms_selected.append(func(gradnorms[i:i+4]))\n",
    "        recalls_selected.append(func(recalls[i:i+4]))\n",
    "        ids_selected.append(ids[i])\n",
    "            \n",
    "    return recalls_selected, gradnorms_selected, ids_selected\n",
    "\n",
    "\n",
    "\n",
    "ood_all = pth + \"ood_all\"\n",
    "recalls, gradnorms, ids = get_recall_and_score_list(ood_all)\n",
    "print(len(recalls), len(gradnorms), len(ids))\n",
    "\n",
    "import matplotlib.pyplot as plt \n",
    "plt.figure()\n",
    "plt.scatter(recalls, gradnorms, color=\"green\")\n",
    "plt.xlabel(\"recall\")\n",
    "plt.ylabel(\"gradient norm\")\n",
    "#plt.plot(ood_well_o, len(ood_well_o) * [0], \"o\" , label = \"ood-well(tp_over_t>0.4)\", color=\"blue\")\n",
    "#plt.plot(ood_poor, len(ood_poor) * [1], \"x\" , label = \"ood-poor\", color=\"red\")\n",
    "\n",
    "means = {k: [] for k in set(recalls)}\n",
    "for r, g in zip(recalls, gradnorms):\n",
    "    means[r].append(g)\n",
    "means = {k: sum(v) / len(v) for k, v in means.items()}\n",
    "means = sorted(list(means.items()), key= lambda x: int(x[0]))\n",
    "xs = [i[0] for i in means]\n",
    "ys = [i[1] for i in means]\n",
    "plt.scatter(xs, ys, marker=\"x\", color=\"red\")\n",
    "plt.legend()\n",
    " "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "8e682e93-a014-4b8a-b2a4-b8e6df3dd99c",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 113,
   "id": "aa052437-ed1b-4e8c-a0b5-121f83c8e24e",
   "metadata": {},
   "outputs": [],
   "source": [
    "data = {\n",
    "    \"_id\": ids,\n",
    "    \"recall\": recalls,\n",
    "    \"grad_norms\": gradnorms,\n",
    "    \"scores\": scores\n",
    "}\n",
    "import pandas as pd\n",
    "df = pd.DataFrame(data)\n",
    "df = df.sort_values(\"recall\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 114,
   "id": "ea598fa8-18c1-4f14-b977-c37f0a6fd7d2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>_id</th>\n",
       "      <th>recall</th>\n",
       "      <th>grad_norms</th>\n",
       "      <th>scores</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>170</th>\n",
       "      <td>qvz63m93</td>\n",
       "      <td>0.0</td>\n",
       "      <td>67.400</td>\n",
       "      <td>[93.6, 91.5, 92.2, 92.0, 92.1, 92.1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>162</th>\n",
       "      <td>qvz63m93</td>\n",
       "      <td>0.0</td>\n",
       "      <td>77.260</td>\n",
       "      <td>[93.8, 92.7, 92.6, 92.3, 92.7, 91.2]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>157</th>\n",
       "      <td>8t35z4gl</td>\n",
       "      <td>0.0</td>\n",
       "      <td>30.120</td>\n",
       "      <td>[94.1, 90.4, 91.8, 90.5, 90.0, 90.1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>wm6yey1v</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.365</td>\n",
       "      <td>[95.2, 87.4, 85.5, 87.5, 87.3, 86.9]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>485</th>\n",
       "      <td>s33brsk6</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.200</td>\n",
       "      <td>[98.4, 90.7, 90.2, 89.9, 89.7, 89.5]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>406</th>\n",
       "      <td>sqrn6kjy</td>\n",
       "      <td>0.0</td>\n",
       "      <td>46.190</td>\n",
       "      <td>[94.3, 90.1, 88.1, 92.0, 91.9, 91.9]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>404</th>\n",
       "      <td>023h20vk</td>\n",
       "      <td>0.0</td>\n",
       "      <td>20.100</td>\n",
       "      <td>[94.3, 90.3, 90.7, 91.0, 90.9, 90.5]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>402</th>\n",
       "      <td>gdl4l9xo</td>\n",
       "      <td>0.0</td>\n",
       "      <td>84.910</td>\n",
       "      <td>[92.5, 91.4, 91.2, 90.3, 90.9, 91.2]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>401</th>\n",
       "      <td>dkxi8mgw</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.188</td>\n",
       "      <td>[94.6, 85.0, 85.4, 86.6, 86.2, 84.3]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>399</th>\n",
       "      <td>nph01vl6</td>\n",
       "      <td>0.0</td>\n",
       "      <td>21.140</td>\n",
       "      <td>[94.3, 91.0, 90.5, 91.0, 90.3, 91.1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>393</th>\n",
       "      <td>vznb3puk</td>\n",
       "      <td>0.0</td>\n",
       "      <td>18.670</td>\n",
       "      <td>[93.0, 88.9, 89.7, 88.7, 89.0, 89.0]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>186</th>\n",
       "      <td>g4qak0bu</td>\n",
       "      <td>0.0</td>\n",
       "      <td>20.090</td>\n",
       "      <td>[94.8, 91.7, 91.3, 91.0, 91.0, 90.5]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184</th>\n",
       "      <td>nph01vl6</td>\n",
       "      <td>0.0</td>\n",
       "      <td>37.930</td>\n",
       "      <td>[94.3, 90.8, 91.9, 92.2, 89.6, 89.5]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>176</th>\n",
       "      <td>dkxi8mgw</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.260</td>\n",
       "      <td>[94.9, 87.2, 86.1, 85.4, 86.1, 86.8]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>424</th>\n",
       "      <td>vznb3puk</td>\n",
       "      <td>0.0</td>\n",
       "      <td>21.500</td>\n",
       "      <td>[92.3, 88.1, 88.0, 88.5, 87.8, 89.3]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>168</th>\n",
       "      <td>703febui</td>\n",
       "      <td>0.0</td>\n",
       "      <td>41.000</td>\n",
       "      <td>[91.6, 88.1, 88.9, 88.1, 88.0, 88.1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>451</th>\n",
       "      <td>can1e8ro</td>\n",
       "      <td>0.0</td>\n",
       "      <td>111.600</td>\n",
       "      <td>[92.5, 91.4, 91.6, 91.0, 91.5, 90.8]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>475</th>\n",
       "      <td>p3gswh23</td>\n",
       "      <td>0.0</td>\n",
       "      <td>28.900</td>\n",
       "      <td>[93.8, 90.1, 90.1, 89.7, 90.2, 91.6]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>471</th>\n",
       "      <td>can1e8ro</td>\n",
       "      <td>0.0</td>\n",
       "      <td>74.210</td>\n",
       "      <td>[93.5, 91.5, 92.0, 91.5, 91.2, 91.6]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>465</th>\n",
       "      <td>n15i01tn</td>\n",
       "      <td>0.0</td>\n",
       "      <td>126.000</td>\n",
       "      <td>[91.4, 89.0, 89.0, 89.6, 89.0, 89.6]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          _id  recall  grad_norms                                scores\n",
       "170  qvz63m93     0.0      67.400  [93.6, 91.5, 92.2, 92.0, 92.1, 92.1]\n",
       "162  qvz63m93     0.0      77.260  [93.8, 92.7, 92.6, 92.3, 92.7, 91.2]\n",
       "157  8t35z4gl     0.0      30.120  [94.1, 90.4, 91.8, 90.5, 90.0, 90.1]\n",
       "150  wm6yey1v     0.0       0.365  [95.2, 87.4, 85.5, 87.5, 87.3, 86.9]\n",
       "485  s33brsk6     0.0       0.200  [98.4, 90.7, 90.2, 89.9, 89.7, 89.5]\n",
       "406  sqrn6kjy     0.0      46.190  [94.3, 90.1, 88.1, 92.0, 91.9, 91.9]\n",
       "404  023h20vk     0.0      20.100  [94.3, 90.3, 90.7, 91.0, 90.9, 90.5]\n",
       "402  gdl4l9xo     0.0      84.910  [92.5, 91.4, 91.2, 90.3, 90.9, 91.2]\n",
       "401  dkxi8mgw     0.0       0.188  [94.6, 85.0, 85.4, 86.6, 86.2, 84.3]\n",
       "399  nph01vl6     0.0      21.140  [94.3, 91.0, 90.5, 91.0, 90.3, 91.1]\n",
       "393  vznb3puk     0.0      18.670  [93.0, 88.9, 89.7, 88.7, 89.0, 89.0]\n",
       "186  g4qak0bu     0.0      20.090  [94.8, 91.7, 91.3, 91.0, 91.0, 90.5]\n",
       "184  nph01vl6     0.0      37.930  [94.3, 90.8, 91.9, 92.2, 89.6, 89.5]\n",
       "176  dkxi8mgw     0.0       0.260  [94.9, 87.2, 86.1, 85.4, 86.1, 86.8]\n",
       "424  vznb3puk     0.0      21.500  [92.3, 88.1, 88.0, 88.5, 87.8, 89.3]\n",
       "168  703febui     0.0      41.000  [91.6, 88.1, 88.9, 88.1, 88.0, 88.1]\n",
       "451  can1e8ro     0.0     111.600  [92.5, 91.4, 91.6, 91.0, 91.5, 90.8]\n",
       "475  p3gswh23     0.0      28.900  [93.8, 90.1, 90.1, 89.7, 90.2, 91.6]\n",
       "471  can1e8ro     0.0      74.210  [93.5, 91.5, 92.0, 91.5, 91.2, 91.6]\n",
       "465  n15i01tn     0.0     126.000  [91.4, 89.0, 89.0, 89.6, 89.0, 89.6]"
      ]
     },
     "execution_count": 114,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head(20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 115,
   "id": "95d5115c-2e8f-47b4-9452-0f1ce3393977",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>_id</th>\n",
       "      <th>recall</th>\n",
       "      <th>grad_norms</th>\n",
       "      <th>scores</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>246</th>\n",
       "      <td>itu39mln</td>\n",
       "      <td>1.0</td>\n",
       "      <td>31.990</td>\n",
       "      <td>[93.1, 88.6, 90.2, 90.0, 90.4, 89.3]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>233</th>\n",
       "      <td>yrrz7oef</td>\n",
       "      <td>1.0</td>\n",
       "      <td>33.450</td>\n",
       "      <td>[91.9, 89.6, 88.5, 88.9, 87.6, 87.8]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>238</th>\n",
       "      <td>7lk8h93q</td>\n",
       "      <td>1.0</td>\n",
       "      <td>79.550</td>\n",
       "      <td>[91.8, 89.8, 89.8, 88.8, 89.8, 90.6]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>254</th>\n",
       "      <td>959w9sln</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.049</td>\n",
       "      <td>[95.1, 84.6, 84.4, 84.6, 84.8, 85.2]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>550</th>\n",
       "      <td>w94b4aft</td>\n",
       "      <td>1.0</td>\n",
       "      <td>9.019</td>\n",
       "      <td>[94.4, 88.7, 88.8, 90.2, 89.9, 90.1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>542</th>\n",
       "      <td>959w9sln</td>\n",
       "      <td>1.0</td>\n",
       "      <td>12.810</td>\n",
       "      <td>[89.1, 85.0, 84.4, 85.0, 84.4, 84.9]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>492</th>\n",
       "      <td>22vz79nz</td>\n",
       "      <td>1.0</td>\n",
       "      <td>4.726</td>\n",
       "      <td>[95.1, 89.7, 89.7, 89.9, 90.0, 89.6]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>517</th>\n",
       "      <td>tdvb0fhv</td>\n",
       "      <td>1.0</td>\n",
       "      <td>28.010</td>\n",
       "      <td>[92.3, 88.6, 89.4, 87.6, 89.1, 88.6]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>496</th>\n",
       "      <td>t3sjv4hv</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.949</td>\n",
       "      <td>[95.2, 88.9, 88.9, 90.1, 88.4, 89.6]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>tdvb0fhv</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.115</td>\n",
       "      <td>[98.1, 88.0, 88.5, 88.7, 88.1, 90.1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>523</th>\n",
       "      <td>w94b4aft</td>\n",
       "      <td>1.0</td>\n",
       "      <td>12.550</td>\n",
       "      <td>[94.0, 89.9, 89.9, 87.2, 89.9, 89.8]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>312</th>\n",
       "      <td>59492sjb</td>\n",
       "      <td>1.0</td>\n",
       "      <td>24.310</td>\n",
       "      <td>[95.2, 90.2, 91.8, 92.7, 91.2, 91.2]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>car394ou</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.011</td>\n",
       "      <td>[99.0, 86.8, 86.6, 87.8, 88.0, 87.1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>04awj06g</td>\n",
       "      <td>1.0</td>\n",
       "      <td>19.190</td>\n",
       "      <td>[92.0, 88.4, 87.6, 88.1, 88.4, 86.3]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>7lk8h93q</td>\n",
       "      <td>1.0</td>\n",
       "      <td>71.600</td>\n",
       "      <td>[91.9, 90.5, 90.7, 89.1, 89.7, 89.2]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>22vz79nz</td>\n",
       "      <td>1.0</td>\n",
       "      <td>7.692</td>\n",
       "      <td>[95.0, 90.3, 90.6, 90.4, 90.6, 90.2]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>310</th>\n",
       "      <td>tdvb0fhv</td>\n",
       "      <td>1.0</td>\n",
       "      <td>39.560</td>\n",
       "      <td>[92.3, 87.8, 88.4, 86.6, 90.9, 87.6]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>296</th>\n",
       "      <td>car394ou</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.189</td>\n",
       "      <td>[95.4, 86.8, 86.5, 86.8, 85.9, 87.3]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>560</th>\n",
       "      <td>378cfb23</td>\n",
       "      <td>1.0</td>\n",
       "      <td>40.730</td>\n",
       "      <td>[92.1, 89.0, 88.8, 89.4, 88.6, 89.7]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>500</th>\n",
       "      <td>ectly1v4</td>\n",
       "      <td>1.0</td>\n",
       "      <td>38.070</td>\n",
       "      <td>[95.3, 92.5, 93.5, 90.9, 90.0, 92.6]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          _id  recall  grad_norms                                scores\n",
       "246  itu39mln     1.0      31.990  [93.1, 88.6, 90.2, 90.0, 90.4, 89.3]\n",
       "233  yrrz7oef     1.0      33.450  [91.9, 89.6, 88.5, 88.9, 87.6, 87.8]\n",
       "238  7lk8h93q     1.0      79.550  [91.8, 89.8, 89.8, 88.8, 89.8, 90.6]\n",
       "254  959w9sln     1.0       0.049  [95.1, 84.6, 84.4, 84.6, 84.8, 85.2]\n",
       "550  w94b4aft     1.0       9.019  [94.4, 88.7, 88.8, 90.2, 89.9, 90.1]\n",
       "542  959w9sln     1.0      12.810  [89.1, 85.0, 84.4, 85.0, 84.4, 84.9]\n",
       "492  22vz79nz     1.0       4.726  [95.1, 89.7, 89.7, 89.9, 90.0, 89.6]\n",
       "517  tdvb0fhv     1.0      28.010  [92.3, 88.6, 89.4, 87.6, 89.1, 88.6]\n",
       "496  t3sjv4hv     1.0       2.949  [95.2, 88.9, 88.9, 90.1, 88.4, 89.6]\n",
       "93   tdvb0fhv     1.0       0.115  [98.1, 88.0, 88.5, 88.7, 88.1, 90.1]\n",
       "523  w94b4aft     1.0      12.550  [94.0, 89.9, 89.9, 87.2, 89.9, 89.8]\n",
       "312  59492sjb     1.0      24.310  [95.2, 90.2, 91.8, 92.7, 91.2, 91.2]\n",
       "17   car394ou     1.0       0.011  [99.0, 86.8, 86.6, 87.8, 88.0, 87.1]\n",
       "9    04awj06g     1.0      19.190  [92.0, 88.4, 87.6, 88.1, 88.4, 86.3]\n",
       "10   7lk8h93q     1.0      71.600  [91.9, 90.5, 90.7, 89.1, 89.7, 89.2]\n",
       "12   22vz79nz     1.0       7.692  [95.0, 90.3, 90.6, 90.4, 90.6, 90.2]\n",
       "310  tdvb0fhv     1.0      39.560  [92.3, 87.8, 88.4, 86.6, 90.9, 87.6]\n",
       "296  car394ou     1.0       0.189  [95.4, 86.8, 86.5, 86.8, 85.9, 87.3]\n",
       "560  378cfb23     1.0      40.730  [92.1, 89.0, 88.8, 89.4, 88.6, 89.7]\n",
       "500  ectly1v4     1.0      38.070  [95.3, 92.5, 93.5, 90.9, 90.0, 92.6]"
      ]
     },
     "execution_count": 115,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.tail(20)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
